Search Drug Information, Interactions, Images, Dosage & Side Effects

Efpeglenatide reduces MACE, kidney events in high-risk patients with T2D 23 Jul 2021

In patients with type 2 diabetes (T2D) with cardiovascular (CV) risk factors or impaired kidney function, weekly doses of the exendin-based GLP-1* receptor agonist (RA) efpeglenatide may reduce their risk of major adverse cardiovascular events (MACE) or kidney outcomes, according to findings from the AMPLITUDE-O trial presented at ADA 2021.

Older age, unemployment, solo living discourage people from exercising

23 Jul 2021

Wearable sensor passes initial test for automatic all-seizure detection

23 Jul 2021

Cirrhosis due to NASH tied to worse outcomes relative to HBV

23 Jul 2021

Drinking green tea daily helps prevent T2D, diabetic complications, says study

23 Jul 2021

Medication treatment lacking in cirrhotic veterans with active opioid use disorder

23 Jul 2021

Real-world data back remdesivir benefit for hospitalized COVID-19 patients

23 Jul 2021

External compression device reduces reflux symptoms when used as PPI adjunct

23 Jul 2021

Mail-out faecal immunochemical test kits help increase CRC screening

23 Jul 2021

Insufficient sleep induces persistent elevation in blood pressure

23 Jul 2021

High chlordane exposure ups diabetes risk

22 Jul 2021

Using Enstilar® in patients with plaque psoriasis before initiation of phototherapy or systemic therapy 01 Jul 2021;
Psoriasis is a chronic inflammatory skin disease and can be classified as ‘mild’, ‘moderate’, or ‘severe’. The management of psoriasis should always be based on its severity and individual patient preferences – it should not be more unpleasant than the disease itself. The two most commonly prescribed classes of topical treatment for psoriasis are vitamin D analogues and topical corticosteroids. In this case study, Dr Tan Wooi Chiang shares his clinical experience treating plaque psoriasis with a combined formulation of betamethasone dipropionate and calcipotriol monohydrate in a single spray foam (Enstilar® Foam, LEO Pharma).

Using Enstilar® in patients with severe psoriasis planned for systemic treatment

01 Jul 2021

Burden of pneumococcal disease among risk groups, pneumococcal vaccination strategies and recommendations among adults: Local and Global perspectives

01 Jul 2021

Product Highlight - PREVYMIS

16 Jun 2021

Relizema/DermaRel

Contents : Relizema cream Aqua, hydrogenated polydecene, ethylhexyl palmitate, dimethicone, glycerin, glyceryl stearate, PEG-100 stearate, cetearyl alcohol, Mg stearate, Ricinus communis seed oil, phenoxyethanol, ascorbyl palmitate, disodium EDTA, ethylhexylglycerin, furfuryl palmitate, ethyl linolenate, tocopheryl acetate, Na hyaluronate, ethyl oleate, ethyl linoleate, propyl gallate, tocopherol, ethyl palmitate, ethyl stearate. DermaRel Ultra Hydrating Lotion Aqua, Butyrospermum parkii butter, hydrogenated polyisobutene, ethylhexyl stearate, glycerin, cetearyl alcohol, methylpropanediol, cetearyl glucoside, caprylyl glycol, K cetyl phosphate, xanthan gum, phenylpropanol, Linum usitatissimum seed oil, Prunus amygdalus dulcis oil, Olea europaea fruit oil, disodium EDTA, C12-15 alkyl benzoate, Borago officinalis seed oil, tribehenin, Na lauroyl lactylate, Na hydroxide, tocopherol, ceramide NG, PEG-10 phytosterol, ceramide NP, phenoxyethanol, lactic acid, ceramide AP, phytosphingosine, cholesterol, carbomer, ethylhexylglycerin, palmitoyl hexapeptide-12, ceramide EOP. DermaRel Lipid-Replenishing Cleanser Aqua, methylpropanediol, disodium cocoamphodiacetate, cocamidopropyl betaine, PEG-7 glyceryl cocoate, carbomer, caprylyl glycol, NaCl, acrylates/C10-30 alkyl acrylate crosspolymer, phenethyl alcohol, Na hydroxide, phenylpropanol, niacinamide, disodium EDTA, glycine, proline, ethylhexylglycerin, Na benzoate, arginine, Na lauroyl lactylate, pentylene glycol, glycerin, urea, citric acid, fructose, ceramide NP, phenoxyethanol, Na lactate, trehalose, allantoin, phytosphingosine, ceramide AP, maltose, Na PCA, cholesterol, xanthan gum, Na hyaluronate, glucose, ceramide EOP. DermaRel Spray & Go Aqua, Zn oxide, cetearyl isononanoate, glycerin, C12-13 alkyl lactate, kaolin, talc, taurine, glyceryl stearate, ethylhexylglycerin, Zn gluconate, Mg Al silicate, ceteareth-20, Chondrus crispus powd, ceteareth-12, cetearyl alcohol, cetyl palmitate, panthenol, Butyrospermum parkii butter, hexamidine diisethionate, citric acid

Indications/Uses : Relizema cream Symptomatic treatment of dermatitis & erythema. Itching & flushing associated w/ dermatitis including atopic & contact dermatitis. DermaRel Ultra Hydrating Lotion Hydrates, moisturises & protects sensitive & dry skin of adults & childn. DermaRel Lipid-Replenishing Cleanser Cleanses, hydrates, moisturizes & protects dry & sensitive face & body skin of adults & childn. DermaRel Spray & Go Protects & soothes delicate & sensitive skin of babies & elderly.